CTHRC1 and neoplasm: Indeed, this anti-fibrotic agent induces apoptotic cell death of CAFs residing among NSCLC cells [225] and decreases the expression of collagen triple helix repeat containing 1 (CTHRC1), which is associated with tumor aggressiveness and poor clinical outcomes for NSCLC patients [226].